BenevolentAI is using machine learning to gather insights from the body of pharmaceutical literature in order to produce new potential drugs, but can it keep top talent?
BenevolentAI is using machine learning to gather insights from the body of pharmaceutical literature in order to produce new potential drugs, but can it keep top talent?